Handbook of Diagnosis and Treatment of Bipolar Disorders
Author(s): Terence A. Ketter (Author)
Publisher: American Psychiatric Publishing, Inc.
Publication Date: 30 Sept. 2009
Edition: 1st
Language: English
Print length: 875 pages
ISBN-10: 9781585623136
ISBN-13: 9781585623136
Book Description
This is the first book to provide quantitative assessment of potential benefit (number needed to treat) and risk (number needed to harm) for all approved treatments for bipolar disorder, providing clinicians with information needed to balance benefits and risks in order to render individualized state-of-the-art, evidence-based care. It describes all FDA-approved indications – reviewing efficacy, safety, tolerability, pharmacokinetics, illness phase – specific dosing, and drug interactions. The book then demonstrates the relevance of this approach to therapeutics by providing: an overview of pharmacotherapy that covers the emergence of evidence-based pharmacotherapy; guidelines to managing acute manic and mixed episodes that include evidence-based assessments; coverage of acute major depressive episodes in bipolar disorders; discussion of the longer-term management of bipolar disorders; a review of the use of mood stabilizers and second-generation antipsychotics, often in combinations; description of important advances in evidence-based adjunctive psychotherapeutic interventions in bipolar depression, and bipolar maintenance treatment. The manual provides information regarding diagnosis, pharmacotherapy, psychotherapy, and treatment of patients from special populations – such as children, women, and older adults – and patients with particularly challenging illness courses such as rapid cycling. Comprehensive in scope, yet readily accessible for application to clinical practice, the book includes summary tables, quick-reference lists of clinical pearls, and case studies.
Editorial Reviews
Review
Select Guide Rating
From the Inside Flap
This readable guide to the assessment and management of patients with bipolar disorder can help physicians keep abreast of dramatic and rapid advances of recent years and integrate them into their practice. Handbook of Diagnosis and Treatment of Bipolar Disorders emphasizes recent controlled studies and U.S. Food and Drug Administration (FDA)–approved indications and translates these data into the real world of clinical practice. The contributions of the eleven chapter authors from Stanford University reflect more than a decade of clinical research and treatment undertaken at that institution, including advances in diagnosis and interventions supported by controlled studies. The manual provides crucial information regarding diagnosis, pharmacotherapy, psychotherapy, and treatment of patients from special populations — such as children, women, and older adults — and patients with particularly challenging illness courses such as rapid cycling.
This is the first book to provide quantitative assessment of potential benefit (number needed to treat) and risk (number needed to harm) for all approved treatments for bipolar disorder, providing clinicians with information needed to balance benefits and risks in order to render individualized state-of-the-art, evidence-based care. The manual describes all FDA-approved therapies — reviewing efficacy, safety, tolerability, pharmacokinetics, illness phase–specific dosing, and drug interactions — and summarizes published therapeutic data, as well as results of randomized controlled clinical trials very recently presented at major scientific conferences.
From the Back Cover
This readable guide to the assessment and management of patients with bipolar disorder can help physicians keep abreast of dramatic and rapid advances of recent years and integrate them into their practice. Handbook of Diagnosis and Treatment of Bipolar Disorders emphasizes recent controlled studies and U.S. Food and Drug Administration (FDA)-approved indications and translates these data into the real world of clinical practice. The contributions of the eleven chapter authors from Stanford University reflect more than a decade of clinical research and treatment undertaken at that institution, including advances in diagnosis and interventions supported by controlled studies. The manual provides crucial information regarding diagnosis, pharmacotherapy, psychotherapy, and treatment of patients from special populations–such as children, women, and older adults–and patients with particularly challenging illness courses such as rapid cycling.
This is the first book to provide quantitative assessment of potential benefit (number needed to treat) and risk (number needed to harm) for all approved treatments for bipolar disorder, providing clinicians with information needed to balance benefits and risks in order to render individualized state-of-the-art, evidence-based care. The manual describes all FDA-approved therapies–reviewing efficacy, safety, tolerability, pharmacokinetics, illness phase-specific dosing, and drug interactions–and summarizes published therapeutic data, as well as results of randomized controlled clinical trials very recently presented at major scientific conferences.
About the Author
Terence A. Ketter, M.D., is Professor of Psychiatry and Behavioral Sciences in the Department of Psychiatry and Behavioral Sciences, and Chief of the Bipolar Disorders Clinic at Stanford University School of Medicine in Stanford, California.
Wow! eBook
